Reappraisal of BCL3 as a molecular marker of anaplastic large cell lymphoma (Q36420017)

14 August 2017

1 reference

title

Reappraisal of BCL3 as a molecular marker of anaplastic large cell lymphoma (English)

1 reference

14 August 2017

Hitoshi Ohno

1

1 reference

14 August 2017

Momoko Nishikori

series ordinal

2

1 reference

14 August 2017

Yoshitomo Maesako

series ordinal

3

1 reference

14 August 2017

Hironori Haga

series ordinal

4

1 reference

14 August 2017

1 December 2005

1 reference

International Journal of Hematology

14 August 2017

1 reference

14 August 2017

82

1 reference

14 August 2017

5

1 reference

14 August 2017

397-405

1 reference

https://scigraph.springernature.com/pub.10.1532/ijh97.05045

14 August 2017

0 references

cites work

High-level expression of BCL3 differentiates t(2;5)(p23;q35)-positive anaplastic large cell lymphoma from Hodgkin disease

1 reference

12 December 2020

Immunological adjuvants promote activated T cell survival via induction of Bcl-3.

1 reference

12 December 2020

Association of C-MYC amplification with progression from the in situ to the invasive stage in C-MYC-amplified breast carcinomas.

1 reference

12 December 2020

Amplification of cyclin D1 in squamous cell carcinoma of the head and neck and the prognostic value of chromosomal abnormalities and cyclin D1 overexpression

1 reference

12 December 2020

Detection of differentially expressed genes in lymphomas using cDNA arrays: identification of clusterin as a new diagnostic marker for anaplastic large-cell lymphomas

1 reference

12 December 2020

Identification of a transcriptional unit adjacent to the breakpoint in the 14;19 translocation of chronic lymphocytic leukemia

1 reference

12 December 2020

CD30(+) anaplastic large cell lymphoma: a review of its histopathologic, genetic, and clinical features

1 reference

12 December 2020

Critical roles for the Bcl-3 oncoprotein in T cell-mediated immunity, splenic microarchitecture, and germinal center reactions

1 reference

12 December 2020

Differential effects of CD30 activation in anaplastic large cell lymphoma and Hodgkin disease cells

1 reference

12 December 2020

Genomic structure of the candidate proto-oncogene BCL3.

1 reference

12 December 2020

t(14;19)(q32;q13): A recurrent translocation in B-cell precursor acute lymphoblastic leukemia

1 reference

12 December 2020

Stimulation of CD30 in anaplastic large cell lymphoma leads to production of nuclear factor-kappaB p52, which is associated with hyperphosphorylated Bcl-3

1 reference

12 December 2020

Involvement of the BCL3 gene in two patients with chronic lymphocytic leukemia

1 reference

12 December 2020

Improved DNA-based polymerase chain reaction amplification of t(2;5)(p23;q35) breakpoints

1 reference

12 December 2020

Hodgkin and Reed-Sternberg cells harbor alterations in the major tumor suppressor pathways and cell-cycle checkpoints: analyses using tissue microarrays

1 reference

12 December 2020

Hodgkin's lymphoma and CD30 signal transduction

1 reference

12 December 2020

The role of immunoglobulin translocations in the pathogenesis of B-cell malignancies

1 reference

12 December 2020

Clonal deleterious mutations in the IkappaBalpha gene in the malignant cells in Hodgkin's lymphoma

1 reference

12 December 2020

T cell receptor-dependent cell death of T cell hybridomas mediated by the CD30 cytoplasmic domain in association with tumor necrosis factor receptor-associated factors

1 reference

12 December 2020

The NPM-ALK oncoprotein abrogates CD30 signaling and constitutive NF-kappaB activation in anaplastic large cell lymphoma

1 reference

12 December 2020

Molecular cloning and expression of a new member of the nerve growth factor receptor family that is characteristic for Hodgkin's disease

1 reference

12 December 2020

NF-kappaB/Rel-mediated regulation of apoptosis in hematologic malignancies and normal hematopoietic progenitors.

1 reference

12 December 2020

Translocations involving anaplastic lymphoma kinase (ALK).

1 reference

12 December 2020

The candidate oncoprotein Bcl-3 is an antagonist of p50/NF-kappa B-mediated inhibition

1 reference

12 December 2020

Differential expression of BCL-2 family proteins in ALK-positive and ALK-negative anaplastic large cell lymphoma of T/null-cell lineage

1 reference

12 December 2020

Survivin expression predicts poorer prognosis in anaplastic large-cell lymphoma

1 reference

12 December 2020

Lymphadenopathy, splenomegaly, and altered immunoglobulin production in BCL3 transgenic mice.

1 reference

12 December 2020

The candidate proto-oncogene bcl-3 encodes a transcriptional coactivator that activates through NF-kappa B p50 homodimers

1 reference

12 December 2020

BCL3 rearrangements and t(14;19) in chronic lymphocytic leukemia and other B-cell malignancies: a molecular and cytogenetic study

1 reference

12 December 2020

Activation of nuclear factor-kappaB p50 homodimer/Bcl-3 complexes in nasopharyngeal carcinoma

1 reference

12 December 2020

Molecular characterization of the t(14;19)(q32;q13) translocation in chronic lymphocytic leukemia

1 reference

12 December 2020

BCL3 encodes a nuclear protein which can alter the subcellular location of NF-kappa B proteins

1 reference

12 December 2020

High-level nuclear NF-kappa B and Oct-2 is a common feature of cultured Hodgkin/Reed-Sternberg cells

1 reference

12 December 2020

A novel IkappaB protein, IkappaB-zeta, induced by proinflammatory stimuli, negatively regulates nuclear factor-kappaB in the nuclei

1 reference

12 December 2020

The candidate proto-oncogene bcl-3 is related to genes implicated in cell lineage determination and cell cycle control

1 reference

12 December 2020

Selective activation of NF-kappa B subunits in human breast cancer: potential roles for NF-kappa B2/p52 and for Bcl-3

1 reference

12 December 2020

Nuclear factor kappaB-dependent gene expression profiling of Hodgkin's disease tumor cells, pathogenetic significance, and link to constitutive signal transducer and activator of transcription 5a activity

1 reference

12 December 2020

Cloning of the chromosome translocation breakpoint junction of the t(14;19) in chronic lymphocytic leukemia

1 reference

12 December 2020

BCL-3 overexpression in anaplastic lymphoma kinase-positive anaplastic large cell lymphoma.

1 reference

12 December 2020

The oncoprotein Bcl-3 directly transactivates through kappa B motifs via association with DNA-binding p50B homodimers

1 reference

12 December 2020

Nucleophosmin-anaplastic lymphoma kinase of large-cell anaplastic lymphoma is a constitutively active tyrosine kinase that utilizes phospholipase C-gamma to mediate its mitogenicity

1 reference

12 December 2020

I kappa B gamma, a 70 kd protein identical to the C-terminal half of p110 NF-kappa B: a new member of the I kappa B family

1 reference

12 December 2020

Continuous hematopoietic cell lines as model systems for leukemia-lymphoma research

1 reference

12 December 2020

Impaired Negative Selection of T Cells in Hodgkin's Disease Antigen CD30–Deficient Mice

1 reference

12 December 2020

Hodgkin and Reed-Sternberg cells in Hodgkin's disease represent the outgrowth of a dominant tumor clone derived from (crippled) germinal center B cells.

1 reference

12 December 2020

Crystal structure of the ankyrin repeat domain of Bcl-3: a unique member of the IkappaB protein family.

1 reference

12 December 2020

GSK3-mediated BCL-3 phosphorylation modulates its degradation and its oncogenicity

1 reference

12 December 2020

NF-kappaB in cancer: from innocent bystander to major culprit

1 reference

12 December 2020

Nucleophosmin-anaplastic lymphoma kinase associated with anaplastic large-cell lymphoma activates the phosphatidylinositol 3-kinase/Akt antiapoptotic signaling pathway

1 reference

12 December 2020

Bcl-3/IgH translocation (14;19)(q32;q13) in non-Hodgkin's lymphomas

1 reference

12 December 2020

The molecular and cellular origins of Hodgkin's disease

1 reference

12 December 2020

Hundreds of ankyrin-like repeats in functionally diverse proteins: mobile modules that cross phyla horizontally?

1 reference

12 December 2020

I kappa B epsilon, a novel member of the I kappa B family, controls RelA and cRel NF-kappa B activity

1 reference

12 December 2020

Retrovirus-mediated gene transfer of NPM-ALK causes lymphoid malignancy in mice.

1 reference

12 December 2020

Epstein-Barr virus encoded latent membrane protein 1 (LMP1) and TNF receptor associated factors (TRAF): colocalisation of LMP1 and TRAF1 in primary EBV infection and in EBV associated Hodgkin lymphoma

1 reference

12 December 2020

The bcl-3 proto-oncogene encodes a nuclear I kappa B-like molecule that preferentially interacts with NF-kappa B p50 and p52 in a phosphorylation-dependent manner

1 reference

12 December 2020

Analysis of cDNA for human erythrocyte ankyrin indicates a repeated structure with homology to tissue-differentiation and cell-cycle control proteins

1 reference

12 December 2020

Diverse effects of BCL3 phosphorylation on its modulation of NF-kappaB p52 homodimer binding to DNA

1 reference

12 December 2020

A 14;19 translocation in B-cell chronic lymphocytic leukemia: a new recurring chromosome aberration

1 reference

12 December 2020

Identifiers

DOI

10.1532/IJH97.05045

1 reference

Dimensions Publication ID

14 August 2017

0 references

1 reference